Saturday, May, 17, 2008

Craig Stoltz's SharePosts

Vytorin: Three Things You Need to Know

Another week, another set of studies calling into question the benefits and risks of a widely used drug. This time it's Vytorin, a cholesterol-lowering drug that combines a statin (in this case Zocor) with a drug that lowers bad cholesterol a different way (Zetia, aka ezetimibe).  As usual, the story is getting political (Congressional... Read moreChevron

HDL: Harder to Control Than Thought

Most efforts to battle arterial clogging focus on lowering LDL, so called "bad" cholesterol. But higher levels of HDL, the good cholesterol, are also linked to better heart health. A new report shows that efforts to raise HDL with drugs have proven to be trickier, and riskier, than lowering LDL. Let's dig in. Bottom line first ... Read moreChevron

  • Font size font size A A A
  • | Email this page Email this page
  • | AddThis Social Bookmark Button
  • | Report abuse
Healthcare 08